Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP827262.RACuG70uYWYQ4QbrWN9x4OBvsFlNiCq69yCR3hYn4tSxg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP827262.RACuG70uYWYQ4QbrWN9x4OBvsFlNiCq69yCR3hYn4tSxg130_assertion type Assertion NP827262.RACuG70uYWYQ4QbrWN9x4OBvsFlNiCq69yCR3hYn4tSxg130_head.
- NP827262.RACuG70uYWYQ4QbrWN9x4OBvsFlNiCq69yCR3hYn4tSxg130_assertion description "[The results indicated that all three NIH 3T3 transformants, 11 of 24 (46%) SCCs, and 5 of 16 (31%) BCCs contained mutations at the second position of Ha-ras codon 12 (GGC----GTC), predicting a glycine-to-valine amino acid substitution, whereas only 1 of 40 skin cancers (an SCC) displayed a mutation in the first position of Ki-ras codon 12 (GGT----AGT), predicting a glycine-to-serine amino acid change.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP827262.RACuG70uYWYQ4QbrWN9x4OBvsFlNiCq69yCR3hYn4tSxg130_provenance.
- NP827262.RACuG70uYWYQ4QbrWN9x4OBvsFlNiCq69yCR3hYn4tSxg130_assertion evidence source_evidence_literature NP827262.RACuG70uYWYQ4QbrWN9x4OBvsFlNiCq69yCR3hYn4tSxg130_provenance.
- NP827262.RACuG70uYWYQ4QbrWN9x4OBvsFlNiCq69yCR3hYn4tSxg130_assertion SIO_000772 2064725 NP827262.RACuG70uYWYQ4QbrWN9x4OBvsFlNiCq69yCR3hYn4tSxg130_provenance.
- NP827262.RACuG70uYWYQ4QbrWN9x4OBvsFlNiCq69yCR3hYn4tSxg130_assertion wasDerivedFrom befree-2016 NP827262.RACuG70uYWYQ4QbrWN9x4OBvsFlNiCq69yCR3hYn4tSxg130_provenance.
- NP827262.RACuG70uYWYQ4QbrWN9x4OBvsFlNiCq69yCR3hYn4tSxg130_assertion wasGeneratedBy ECO_0000203 NP827262.RACuG70uYWYQ4QbrWN9x4OBvsFlNiCq69yCR3hYn4tSxg130_provenance.